风湿性关节炎-话题@MedSci

#风湿性关节炎#

429篇内容 | 6816人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1483663, encodeId=3ee8148366378, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎患病前后的乳腺癌风险以及激素因子的影响, objectType=article, longId=190263, objectId=122b19026304, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=122b19026304, replyNumber=0, likeNumber=73, createdTime=2020-03-20, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=122b19026304, moduleTitle=Ann Rheum Dis：类风湿性关节炎患病前后的乳腺癌风险以及激素因子的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=122b19026304)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483662, encodeId=0f001483662d6, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Arthritis Rheumatol：类风湿性关节炎的医师处方模式和未来长期使用阿片类药物的风险, objectType=article, longId=189509, objectId=3db7189509c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3db7189509c6, replyNumber=0, likeNumber=55, createdTime=2020-03-08, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3db7189509c6, moduleTitle=Arthritis Rheumatol：类风湿性关节炎的医师处方模式和未来长期使用阿片类药物的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3db7189509c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483661, encodeId=62941483661e5, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Arthritis Rheumatol：女性哮喘、慢阻肺与随后出现类风湿性关节炎的风险, objectType=article, longId=189507, objectId=763a18950e06, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=763a18950e06, replyNumber=0, likeNumber=81, createdTime=2020-03-08, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=763a18950e06, moduleTitle=Arthritis Rheumatol：女性哮喘、慢阻肺与随后出现类风湿性关节炎的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=763a18950e06)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483660, encodeId=9227148366067, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Clinica Chimica Acta：类风湿性关节炎患者白蛋白与纤维蛋白原比值、c反应蛋白与白蛋白比值与Th17细胞的相关性研究, objectType=article, longId=189123, objectId=7b5518912311, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b5518912311, replyNumber=0, likeNumber=0, createdTime=2020-03-03, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b5518912311, moduleTitle=Clinica Chimica Acta：类风湿性关节炎患者白蛋白与纤维蛋白原比值、c反应蛋白与白蛋白比值与Th17细胞的相关性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b5518912311)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483659, encodeId=57481483659cc, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=【盘点】类风湿性关节炎近期治疗新进展, objectType=article, longId=189033, objectId=908718903332, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=908718903332, replyNumber=0, likeNumber=76, createdTime=2020-03-02, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=908718903332, moduleTitle=【盘点】类风湿性关节炎近期治疗新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=908718903332)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483658, encodeId=15e01483658f7, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Arthritis Rheumatol：两个早期类风湿性关节炎队列实施不同靶向治疗策略达到缓解的情况, objectType=article, longId=189029, objectId=b5d61890294c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5d61890294c, replyNumber=0, likeNumber=126, createdTime=2020-03-02, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5d61890294c, moduleTitle=Arthritis Rheumatol：两个早期类风湿性关节炎队列实施不同靶向治疗策略达到缓解的情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5d61890294c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483657, encodeId=b1cb148365eec, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：血清代谢组和脂质组差异确定了血清阴性类风湿性关节炎vs银屑病关节炎的潜在生物标志物, objectType=article, longId=188887, objectId=a40518888e08, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a40518888e08, replyNumber=0, likeNumber=108, createdTime=2020-02-29, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a40518888e08, moduleTitle=Ann Rheum Dis：血清代谢组和脂质组差异确定了血清阴性类风湿性关节炎vs银屑病关节炎的潜在生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a40518888e08)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483656, encodeId=f99e1483656dd, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎靶向治疗真有效吗？患者队列纵向分析（RA BIODAM）, objectType=article, longId=188886, objectId=2db218888685, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2db218888685, replyNumber=0, likeNumber=70, createdTime=2020-02-29, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2db218888685, moduleTitle=Ann Rheum Dis：类风湿性关节炎靶向治疗真有效吗？患者队列纵向分析（RA BIODAM）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2db218888685)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483655, encodeId=eca3148365574, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Ann Rheum Dis：类风湿性关节炎的流行病学正在改变吗？1985-2014年人群发病率研究结果, objectType=article, longId=188408, objectId=a1b41884087a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1b41884087a, replyNumber=0, likeNumber=62, createdTime=2020-02-21, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1b41884087a, moduleTitle=Ann Rheum Dis：类风湿性关节炎的流行病学正在改变吗？1985-2014年人群发病率研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1b41884087a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483654, encodeId=6fc314836543e, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=2019 EULAR建议：应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎, objectType=article, longId=187487, objectId=545318e487a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=545318e487a7, replyNumber=0, likeNumber=37, createdTime=2020-02-06, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=545318e487a7, moduleTitle=2019 EULAR建议：应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=545318e487a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483653, encodeId=34cc148365357, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=J Rheumatol：IL-17A和IL-17F在类风湿性关节炎和外周型脊椎关节炎中的表达及功能反应, objectType=article, longId=186528, objectId=ba8f18652830, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba8f18652830, replyNumber=0, likeNumber=67, createdTime=2020-01-21, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba8f18652830, moduleTitle=J Rheumatol：IL-17A和IL-17F在类风湿性关节炎和外周型脊椎关节炎中的表达及功能反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba8f18652830)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483652, encodeId=68a8148365210, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=J Rheumatol：托珠单抗对类风湿性关节炎的疗效不受合并症或肥胖的影响, objectType=article, longId=186487, objectId=d18c18648edb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d18c18648edb, replyNumber=0, likeNumber=69, createdTime=2020-01-20, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d18c18648edb, moduleTitle=J Rheumatol：托珠单抗对类风湿性关节炎的疗效不受合并症或肥胖的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d18c18648edb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483651, encodeId=538d148365171, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=J Rheumatol：类风湿性关节炎患者骨质疏松症治疗指南的实施效果评估, objectType=article, longId=186320, objectId=118618632081, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=118618632081, replyNumber=0, likeNumber=72, createdTime=2020-01-17, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=118618632081, moduleTitle=J Rheumatol：类风湿性关节炎患者骨质疏松症治疗指南的实施效果评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=118618632081)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483650, encodeId=8b381483650f4, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=PLos One：康复频率对类风湿性关节炎患者卒中风险的影响, objectType=article, longId=186319, objectId=45ba1863199a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45ba1863199a, replyNumber=0, likeNumber=75, createdTime=2020-01-17, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45ba1863199a, moduleTitle=PLos One：康复频率对类风湿性关节炎患者卒中风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45ba1863199a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483649, encodeId=ce5c14836491b, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=J Rheumatol：类风湿性关节炎临床试验中的安慰剂反应, objectType=article, longId=186267, objectId=a8e218626e3f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8e218626e3f, replyNumber=0, likeNumber=74, createdTime=2020-01-16, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8e218626e3f, moduleTitle=J Rheumatol：类风湿性关节炎临床试验中的安慰剂反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8e218626e3f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483648, encodeId=bbea148364894, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=PLos One：类风湿性关节炎患者生物类改善病情抗风湿药降级的成本-疗效分析, objectType=article, longId=186215, objectId=23e8186215e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23e8186215e9, replyNumber=0, likeNumber=68, createdTime=2020-01-15, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23e8186215e9, moduleTitle=PLos One：类风湿性关节炎患者生物类改善病情抗风湿药降级的成本-疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23e8186215e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483647, encodeId=9daf148364e0e, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Clin Exp Rheumatol：类风湿性关节炎自身抗体水平与疾病活动性的关联取决于基线炎症, objectType=article, longId=186127, objectId=4bd218612e59, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bd218612e59, replyNumber=0, likeNumber=52, createdTime=2020-01-14, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bd218612e59, moduleTitle=Clin Exp Rheumatol：类风湿性关节炎自身抗体水平与疾病活动性的关联取决于基线炎症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bd218612e59)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483646, encodeId=ad3b1483646c5, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Clin Exp Rheumatol：在国际多中心研究中对类风湿性关节炎的新分类标准进行验证, objectType=article, longId=186034, objectId=31e81860342c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31e81860342c, replyNumber=0, likeNumber=72, createdTime=2020-01-12, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31e81860342c, moduleTitle=Clin Exp Rheumatol：在国际多中心研究中对类风湿性关节炎的新分类标准进行验证, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31e81860342c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483645, encodeId=4edf1483645d1, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=艾伯维的口服JAK抑制剂RINVOQ获得加拿大批准，用于治疗中度至重度活动性类风湿性关节炎, objectType=article, longId=185935, objectId=6a1818593535, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a1818593535, replyNumber=0, likeNumber=76, createdTime=2020-01-10, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a1818593535, moduleTitle=艾伯维的口服JAK抑制剂RINVOQ获得加拿大批准，用于治疗中度至重度活动性类风湿性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a1818593535)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1483644, encodeId=5a6f1483644bb, content=<a href='/topic/show?id=55a6100826cc' target=_blank style='color:#2F92EE;'>#风湿性关节炎#</a>, objectTitle=Semin Arthritis Rheu：类风湿性关节炎患者开始和停止阿片类药物治疗的相关因素, objectType=article, longId=185924, objectId=ba7518592435, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba7518592435, replyNumber=0, likeNumber=64, createdTime=2020-01-10, rootId=0, userName=ms1467340776200723, userId=5c237911872, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba7518592435, moduleTitle=Semin Arthritis Rheu：类风湿性关节炎患者开始和停止阿片类药物治疗的相关因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba7518592435)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

风湿性关节炎

2020-05-29发表于威斯康星

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：类风湿性关节炎患病前后的乳腺癌风险以及激素因子的影响

2020-03-20

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Arthritis Rheumatol：类风湿性关节炎的医师处方模式和未来长期使用阿片类药物的风险

2020-03-08

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Arthritis Rheumatol：女性哮喘、慢阻肺与随后出现类风湿性关节炎的风险

2020-03-08

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Clinica Chimica Acta：类风湿性关节炎患者白蛋白与纤维蛋白原比值、c反应蛋白与白蛋白比值与Th17细胞的相关性研究

2020-03-03

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

【盘点】类风湿性关节炎近期治疗新进展

2020-03-02

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Arthritis Rheumatol：两个早期类风湿性关节炎队列实施不同靶向治疗策略达到缓解的情况

2020-03-02

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：血清代谢组和脂质组差异确定了血清阴性类风湿性关节炎vs银屑病关节炎的潜在生物标志物

2020-02-29

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：类风湿性关节炎靶向治疗真有效吗？患者队列纵向分析（RA BIODAM）

2020-02-29

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Ann Rheum Dis：类风湿性关节炎的流行病学正在改变吗？1985-2014年人群发病率研究结果

2020-02-21

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

2019 EULAR建议：应用合成或生物类改善病情抗风湿药治疗类风湿性关节炎

2020-02-06

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

J Rheumatol：IL-17A和IL-17F在类风湿性关节炎和外周型脊椎关节炎中的表达及功能反应

2020-01-21

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

J Rheumatol：托珠单抗对类风湿性关节炎的疗效不受合并症或肥胖的影响

2020-01-20

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

J Rheumatol：类风湿性关节炎患者骨质疏松症治疗指南的实施效果评估

2020-01-17

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

PLos One：康复频率对类风湿性关节炎患者卒中风险的影响

2020-01-17

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

J Rheumatol：类风湿性关节炎临床试验中的安慰剂反应

2020-01-16

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

PLos One：类风湿性关节炎患者生物类改善病情抗风湿药降级的成本-疗效分析

2020-01-15

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Clin Exp Rheumatol：类风湿性关节炎自身抗体水平与疾病活动性的关联取决于基线炎症

2020-01-14

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Clin Exp Rheumatol：在国际多中心研究中对类风湿性关节炎的新分类标准进行验证

2020-01-12

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

艾伯维的口服JAK抑制剂RINVOQ获得加拿大批准，用于治疗中度至重度活动性类风湿性关节炎

2020-01-10

ms1467340776200723 (审核中...)

前往app查看评论内容

#风湿性关节炎#

Semin Arthritis Rheu：类风湿性关节炎患者开始和停止阿片类药物治疗的相关因素

2020-01-10

科室
- - 订阅+
  - 更多科室
工具
服务